IP Library Granted Patent US 9,073,988
Granted Patent B2
US 9,073,988 · App. 14/563,993 · Granted Jul 7, 2015

Fed batch method of making anti-TNF-alpha antibodies

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,073,988
App. No.
14/563,993
Granted
Jul 7, 2015
Kind
B2
Abstract

The invention describes improved methods and compositions for producing a recombinant protein, e.g., an antibody, in mammalian cell culture. In addition, the invention provides improved cell culture media, including improved production media, feed solutions, and combination feeds, which may be used to improve protein productivity in mammalian cell culture.

Claims (27)

1. A fed batch method for making an anti-TNFα antibody comprising a light chain variable region (LCVR) comprising the sequence of SEQ ID NO:1 and a heavy chain variable region (HCVR) comprising the sequence of SEQ ID NO:2, said method comprising culturing mammalian cells comprising a nucleic acid encoding said anti-TNFα antibody in a cell culture production medium in large scale, wherein the pH of the cell culture production medium is adjusted according to a pH linear ramp comprising beginning at a starting pH and ending at a final pH that is less than the starting pH, such that said anti-TNFα antibody is produced, and wherein said produced anti-TNFα antibody is further affinity purified using a Protein A resin.

2. The fed batch method according to claim 1 , wherein the starting pH is 8 or less.

3. The fed batch method according to claim 1 , wherein the final pH is 6.5 to 7.0.

4. The fed batch method according to claim 3 , wherein the starting pH is 8 or less.

5. The fed batch method according to claim 1 , wherein the starting pH is 7.1 to 7.2.

6. The fed batch method according to claim 1 , wherein the final pH is 6.9.

7. The fed batch method according to claim 1 , wherein the starting pH is 6.5 to 8 and the final pH is 6.5 to 7.

8. The fed batch method according to claim 1 , wherein the starting pH is 7.1 and the final pH is 6.9.

9. The fed batch method according to claim 1 , wherein the pH is adjusted over a period of at least 24 hours.

10. The fed batch method according to claim 1 , wherein the pH is adjusted within the first 72 hours of the culturing.

11. The fed batch method according to claim 1 , further comprising supplementing the cell culture production medium, wherein the pH is adjusted prior to the supplementing.

12. The fed batch method according to claim 1 , wherein the mammalian cells are Chinese Hamster Ovary (CHO) cells.

13. The fed batch method according to claim 1 , wherein the pH is adjusted over a period of at least 48 hours.

14. The fed batch method according to claim 1 , wherein the pH is adjusted over a period of at least 72 hours.

15. A fed batch method for making adalimumab, said method comprising culturing mammalian cells comprising a nucleic acid encoding said adalimumab in a cell culture production medium in large scale, wherein the pH of the cell culture production medium is adjusted according to a pH linear ramp comprising beginning at a starting pH and ending at a final pH that is less than the starting pH, such that said adalimumab is produced, and wherein said produced anti-TNFα antibody is further affinity purified using a Protein A resin.

16. The fed batch method according to claim 15 , wherein the starting pH is 8 or less.

17. The fed batch method according to claim 15 , wherein the final pH is 6.5 to 7.0.

18. The fed batch method according to claim 17 , wherein the starting pH is 8 or less.

19. The fed batch method according to claim 15 , wherein the starting pH is 7.1 to 7.2.

20. The fed batch method according to claim 15 , wherein the starting pH is 6.5 to 8 and the final pH is 6.5 to 7.

21. The fed batch method according to claim 15 , wherein the starting pH is 7.1 and the final pH is 6.9.

22. The fed batch method according to claim 15 , wherein the pH is adjusted over a period of at least 24 hours.

23. The fed batch method according to claim 15 , wherein the pH is adjusted within the first 72 hours of the culturing.

24. The fed batch method according to claim 15 , further comprising supplementing the cell culture production medium, wherein the pH is adjusted prior to the supplementing.

25. The fed batch method according to claim 15 , wherein the mammalian cells are Chinese Hamster Ovary (CHO) cells.

26. The fed batch method according to claim 15 , wherein the pH is adjusted over a period of at least 48 hours.

27. The fed batch method according to claim 15 , wherein the pH is adjusted over a period of at least 72 hours.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2015
From: PLA, ITZCOATL A.; MATUCK, JOSEPH G.; FANN, JOHN C.; SCHULZ, CHRISTOF; ROY, NICHOLE A.; BRUTON, DAVID F.
To: ABBOTT LABORATORIES
Reel/Frame 035679/0713 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2015
From: ROY, NICHOLE A.
To: ABBOTT LABORATORIES
Reel/Frame 035679/0731 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2015
From: MCINTIRE, JAMES; CHANG, YU-HSIANG DAVID; SEEWOESTER, THOMAS
To: BASF AKTIENGESELLSCHAFT
Reel/Frame 035679/0734 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2015
From: BASF AKTIENGESELLSCHAFT
To: ABBOTT LABORATORIES
Reel/Frame 035742/0192 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2015
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 035742/0195 →